APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dihydropyridine Vasodilators

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Dihydropyridine Vasodilators Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025197 pages

Choose your research edition.

Industry ResearchDihydropyridine Vasodilators Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Dihydropyridine Vasodilators Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Dihydropyridine Vasodilators Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dihydropyridine Vasodilators Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Dihydropyridine Vasodilators Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Dihydropyridine Vasodilators market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Dihydropyridine Vasodilators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dihydropyridine Vasodilators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dihydropyridine Vasodilators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Dihydropyridine Vasodilators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dihydropyridine Vasodilators include Teva, Sine Pharma, Shyndec Pharma, Huanghai Pharma, Novartis, Nanjing Easeheal Pharma, Lifeon Pharma, Beijing Hongling Pharma and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Dihydropyridine Vasodilators market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dihydropyridine Vasodilators and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dihydropyridine Vasodilators revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Dihydropyridine Vasodilators market size, projected growth trends, production technologies, key applications, and end-use industries.

Dihydropyridine Vasodilators Segment by Company

Teva

Sine Pharma

Shyndec Pharma

Huanghai Pharma

Novartis

Nanjing Easeheal Pharma

Lifeon Pharma

Beijing Hongling Pharma

Bayer

AstraZeneca

Ingenus Pharmaceutical

Hikma Pharmaceuticals

Baxter International

Astellas Pharma

Aguettant

Dihydropyridine Vasodilators Segment by Type

Felodipine

Nicardipine

Nifedipine

Iradipine

Other

Dihydropyridine Vasodilators Segment by Application

Hospital

Retail Pharmacy

Other

Dihydropyridine Vasodilators Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dihydropyridine Vasodilators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dihydropyridine Vasodilators and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dihydropyridine Vasodilators.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Dihydropyridine Vasodilators in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dihydropyridine Vasodilators industry.

Chapter 3: Detailed analysis of Dihydropyridine Vasodilators companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dihydropyridine Vasodilatorsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Dihydropyridine Vasodilators Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Felodipine Table 3. Key Players of Nicardipine Table 4. Key Players of Nifedipine Table 3. Key Players of Iradipine Table 4. Key Players of Other Table 5. Global Dihydropyridine Vasodilators Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Hospital Table 7. Key Players of Retail Pharmacy Table 8. Key Players of Other Table 9. Global Dihydropyridine Vasodilators Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Dihydropyridine Vasodilators Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Dihydropyridine Vasodilators Market Share by Region (2021-2026) Table 12. Global Dihydropyridine Vasodilators Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Dihydropyridine Vasodilators Market Share by Region (2027-2032) Table 14. Dihydropyridine Vasodilators Industry Trends Table 15. Dihydropyridine Vasodilators Industry Drivers Table 16. Dihydropyridine Vasodilators Industry Opportunities and Challenges Table 17. Dihydropyridine Vasodilators Industry Restraints Table 18. Global Dihydropyridine Vasodilators Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Dihydropyridine Vasodilators Revenue Market Share by Company (2021-2026) Table 20. Global Dihydropyridine Vasodilators Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Dihydropyridine Vasodilators Key Company Head Office and Area Served Table 22. Global Dihydropyridine Vasodilators Company, Product Type & Application Table 23. Global Dihydropyridine Vasodilators Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Dihydropyridine Vasodilators by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Dihydropyridine Vasodilators Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Dihydropyridine Vasodilators Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Dihydropyridine Vasodilators Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Dihydropyridine Vasodilators Revenue Market Share by Type (2021-2026) Table 30. Global Dihydropyridine Vasodilators Revenue Market Share by Type (2027-2032) Table 31. Global Dihydropyridine Vasodilators Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Dihydropyridine Vasodilators Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Dihydropyridine Vasodilators Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Dihydropyridine Vasodilators Revenue Market Share by Application (2021-2026) Table 35. Global Dihydropyridine Vasodilators Revenue Market Share by Application (2027-2032) Table 36. Teva Company Information Table 37. Teva Business Overview Table 38. Teva Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Teva Dihydropyridine Vasodilators Product Portfolio Table 40. Teva Recent Development Table 41. Sine Pharma Company Information Table 42. Sine Pharma Business Overview Table 43. Sine Pharma Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Sine Pharma Dihydropyridine Vasodilators Product Portfolio Table 45. Sine Pharma Recent Development Table 46. Shyndec Pharma Company Information Table 47. Shyndec Pharma Business Overview Table 48. Shyndec Pharma Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Shyndec Pharma Dihydropyridine Vasodilators Product Portfolio Table 50. Shyndec Pharma Recent Development Table 51. Huanghai Pharma Company Information Table 52. Huanghai Pharma Business Overview Table 53. Huanghai Pharma Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Huanghai Pharma Dihydropyridine Vasodilators Product Portfolio Table 55. Huanghai Pharma Recent Development Table 56. Novartis Company Information Table 57. Novartis Business Overview Table 58. Novartis Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Novartis Dihydropyridine Vasodilators Product Portfolio Table 60. Novartis Recent Development Table 61. Nanjing Easeheal Pharma Company Information Table 62. Nanjing Easeheal Pharma Business Overview Table 63. Nanjing Easeheal Pharma Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Nanjing Easeheal Pharma Dihydropyridine Vasodilators Product Portfolio Table 65. Nanjing Easeheal Pharma Recent Development Table 66. Lifeon Pharma Company Information Table 67. Lifeon Pharma Business Overview Table 68. Lifeon Pharma Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Lifeon Pharma Dihydropyridine Vasodilators Product Portfolio Table 70. Lifeon Pharma Recent Development Table 71. Beijing Hongling Pharma Company Information Table 72. Beijing Hongling Pharma Business Overview Table 73. Beijing Hongling Pharma Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Beijing Hongling Pharma Dihydropyridine Vasodilators Product Portfolio Table 75. Beijing Hongling Pharma Recent Development Table 76. Bayer Company Information Table 77. Bayer Business Overview Table 78. Bayer Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Bayer Dihydropyridine Vasodilators Product Portfolio Table 80. Bayer Recent Development Table 81. AstraZeneca Company Information Table 82. AstraZeneca Business Overview Table 83. AstraZeneca Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. AstraZeneca Dihydropyridine Vasodilators Product Portfolio Table 85. AstraZeneca Recent Development Table 86. Ingenus Pharmaceutical Company Information Table 87. Ingenus Pharmaceutical Business Overview Table 88. Ingenus Pharmaceutical Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Ingenus Pharmaceutical Dihydropyridine Vasodilators Product Portfolio Table 90. Ingenus Pharmaceutical Recent Development Table 91. Hikma Pharmaceuticals Company Information Table 92. Hikma Pharmaceuticals Business Overview Table 93. Hikma Pharmaceuticals Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Hikma Pharmaceuticals Dihydropyridine Vasodilators Product Portfolio Table 95. Hikma Pharmaceuticals Recent Development Table 96. Baxter International Company Information Table 97. Baxter International Business Overview Table 98. Baxter International Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Baxter International Dihydropyridine Vasodilators Product Portfolio Table 100. Baxter International Recent Development Table 101. Astellas Pharma Company Information Table 102. Astellas Pharma Business Overview Table 103. Astellas Pharma Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. Astellas Pharma Dihydropyridine Vasodilators Product Portfolio Table 105. Astellas Pharma Recent Development Table 106. Aguettant Company Information Table 107. Aguettant Business Overview Table 108. Aguettant Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. Aguettant Dihydropyridine Vasodilators Product Portfolio Table 110. Aguettant Recent Development Table 111. North America Dihydropyridine Vasodilators Market Size by Type (2021-2026) & (US$ Million) Table 112. North America Dihydropyridine Vasodilators Market Size by Type (2027-2032) & (US$ Million) Table 113. North America Dihydropyridine Vasodilators Market Size by Application (2021-2026) & (US$ Million) Table 114. North America Dihydropyridine Vasodilators Market Size by Application (2027-2032) & (US$ Million) Table 115. North America Dihydropyridine Vasodilators Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Dihydropyridine Vasodilators Market Size by Country (2021-2026) Table 117. North America Dihydropyridine Vasodilators Market Size by Country (2027-2032) Table 118. Europe Dihydropyridine Vasodilators Market Size by Type (2021-2026) & (US$ Million) Table 119. Europe Dihydropyridine Vasodilators Market Size by Type (2027-2032) & (US$ Million) Table 120. Europe Dihydropyridine Vasodilators Market Size by Application (2021-2026) & (US$ Million) Table 121. Europe Dihydropyridine Vasodilators Market Size by Application (2027-2032) & (US$ Million) Table 122. Europe Dihydropyridine Vasodilators Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Dihydropyridine Vasodilators Market Size by Country (2021-2026) Table 124. Europe Dihydropyridine Vasodilators Market Size by Country (2027-2032) Table 125. China Dihydropyridine Vasodilators Market Size by Type (2021-2026) & (US$ Million) Table 126. China Dihydropyridine Vasodilators Market Size by Type (2027-2032) & (US$ Million) Table 127. China Dihydropyridine Vasodilators Market Size by Application (2021-2026) & (US$ Million) Table 128. China Dihydropyridine Vasodilators Market Size by Application (2027-2032) & (US$ Million) Table 129. Asia Dihydropyridine Vasodilators Market Size by Type (2021-2026) & (US$ Million) Table 130. Asia Dihydropyridine Vasodilators Market Size by Type (2027-2032) & (US$ Million) Table 131. Asia Dihydropyridine Vasodilators Market Size by Application (2021-2026) & (US$ Million) Table 132. Asia Dihydropyridine Vasodilators Market Size by Application (2027-2032) & (US$ Million) Table 133. Asia Dihydropyridine Vasodilators Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Asia Dihydropyridine Vasodilators Market Size by Country (2021-2026) Table 135. Asia Dihydropyridine Vasodilators Market Size by Country (2027-2032) Table 136. South America, Middle East & Africa Dihydropyridine Vasodilators Market Size by Type (2021-2026) & (US$ Million) Table 137. South America, Middle East & Africa Dihydropyridine Vasodilators Market Size by Type (2027-2032) & (US$ Million) Table 138. South America, Middle East & Africa Dihydropyridine Vasodilators Market Size by Application (2021-2026) & (US$ Million) Table 139. South America, Middle East & Africa Dihydropyridine Vasodilators Market Size by Application (2027-2032) & (US$ Million) Table 140. South America, Middle East & Africa Dihydropyridine Vasodilators Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. South America, Middle East & Africa Dihydropyridine Vasodilators Market Size by Country (2021-2026) Table 142. South America, Middle East & Africa Dihydropyridine Vasodilators Market Size by Country (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Dihydropyridine Vasodilators Product Image Figure 2. Global Dihydropyridine Vasodilators Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Dihydropyridine Vasodilators Market Share by Type: 2025 VS 2032 Figure 4. Felodipine Image Figure 5. Nicardipine Image Figure 6. Nifedipine Image Figure 7. Iradipine Image Figure 8. Other Image Figure 9. Global Dihydropyridine Vasodilators Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Dihydropyridine Vasodilators Market Share by Application: 2025 VS 2032 Figure 11. Hospital Image Figure 12. Retail Pharmacy Image Figure 13. Other Image Figure 14. Global Dihydropyridine Vasodilators Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Dihydropyridine Vasodilators Market Size (2021-2032) & (US$ Million) Figure 16. Global Dihydropyridine Vasodilators Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Dihydropyridine Vasodilators Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Dihydropyridine Vasodilators Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Dihydropyridine Vasodilators Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Dihydropyridine Vasodilators Revenue Market Share by Type (2021-2032) Figure 23. Global Dihydropyridine Vasodilators Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Dihydropyridine Vasodilators Revenue Market Share by Application (2021-2032) Figure 25. North America Dihydropyridine Vasodilators Market Size (2021-2032) & (US$ Million) Figure 26. North America Dihydropyridine Vasodilators Market Share by Type (2021-2032) Figure 27. North America Dihydropyridine Vasodilators Market Share by Application (2021-2032) Figure 28. North America Dihydropyridine Vasodilators Market Share by Country (2021-2032) Figure 29. United States Dihydropyridine Vasodilators Market Size (2021-2032) & (US$ Million) Figure 30. Canada Dihydropyridine Vasodilators Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Dihydropyridine Vasodilators Market Size (2021-2032) & (US$ Million) Figure 32. Europe Dihydropyridine Vasodilators Market Size (2021-2032) & (US$ Million) Figure 33. Europe Dihydropyridine Vasodilators Market Share by Type (2021-2032) Figure 34. Europe Dihydropyridine Vasodilators Market Share by Application (2021-2032) Figure 35. Europe Dihydropyridine Vasodilators Market Share by Country (2021-2032) Figure 36. Germany Dihydropyridine Vasodilators Market Size (2021-2032) & (US$ Million) Figure 37. France Dihydropyridine Vasodilators Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Dihydropyridine Vasodilators Market Size (2021-2032) & (US$ Million) Figure 39. Italy Dihydropyridine Vasodilators Market Size (2021-2032) & (US$ Million) Figure 40. Russia Dihydropyridine Vasodilators Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Dihydropyridine Vasodilators Market Size (2021-2032) & (US$ Million) Figure 42. China Dihydropyridine Vasodilators Market Size (2021-2032) & (US$ Million) Figure 43. China Dihydropyridine Vasodilators Market Share by Type (2021-2032) Figure 44. China Dihydropyridine Vasodilators Market Share by Application (2021-2032) Figure 45. Asia Dihydropyridine Vasodilators Market Size (2021-2032) & (US$ Million) Figure 46. Asia Dihydropyridine Vasodilators Market Share by Type (2021-2032) Figure 47. Asia Dihydropyridine Vasodilators Market Share by Application (2021-2032) Figure 48. Asia Dihydropyridine Vasodilators Market Share by Country (2021-2032) Figure 49. Japan Dihydropyridine Vasodilators Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Dihydropyridine Vasodilators Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Dihydropyridine Vasodilators Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Dihydropyridine Vasodilators Market Size (2021-2032) & (US$ Million) Figure 53. India Dihydropyridine Vasodilators Market Size (2021-2032) & (US$ Million) Figure 54. Australia Dihydropyridine Vasodilators Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Dihydropyridine Vasodilators Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Dihydropyridine Vasodilators Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Dihydropyridine Vasodilators Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Dihydropyridine Vasodilators Market Share by Country (2021-2032) Figure 59. Brazil Dihydropyridine Vasodilators Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Dihydropyridine Vasodilators Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Dihydropyridine Vasodilators Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Dihydropyridine Vasodilators Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Dihydropyridine Vasodilators Market Size (2021-2032) & (US$ Million) Figure 64. UAE Dihydropyridine Vasodilators Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Dihydropyridine Vasodilators Market Size (2021-2032) & (US$ Million) Figure 66. Chile Dihydropyridine Vasodilators Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Felodipine
  • Nicardipine
  • Nifedipine
  • Iradipine
  • Other
Applications
  • Hospital
  • Retail Pharmacy
  • Other
Companies covered
  • Teva
  • Sine Pharma
  • Shyndec Pharma
  • Huanghai Pharma
  • Novartis
  • Nanjing Easeheal Pharma
  • Lifeon Pharma
  • Beijing Hongling Pharma
  • Bayer
  • AstraZeneca
  • Ingenus Pharmaceutical
  • Hikma Pharmaceuticals
  • Baxter International
  • Astellas Pharma
  • Aguettant

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Dihydropyridine Vasodilators Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Felodipine
  5. 1.2.3 Nicardipine
  6. 1.2.4 Nifedipine
  7. 1.2.5 Iradipine
  8. 1.2.6 Other
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Dihydropyridine Vasodilators Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital
  12. 1.3.3 Retail Pharmacy
  13. 1.3.4 Other
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Dihydropyridine Vasodilators Growth Trends by Region
  16. 1.5.1 Global Dihydropyridine Vasodilators Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Dihydropyridine Vasodilators Market Size by Region (2021-2026)
  18. 1.5.3 Dihydropyridine Vasodilators Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Dihydropyridine Vasodilators Market Dynamics
  1. 2.1 Dihydropyridine Vasodilators Industry Trends
  2. 2.2 Dihydropyridine Vasodilators Industry Drivers
  3. 2.3 Dihydropyridine Vasodilators Industry Opportunities and Challenges
  4. 2.4 Dihydropyridine Vasodilators Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Dihydropyridine Vasodilators Revenue by Company (2021-2026)
  2. 3.2 Global Dihydropyridine Vasodilators Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Dihydropyridine Vasodilators Key Company Head office and Area Served
  4. 3.4 Global Dihydropyridine Vasodilators Company, Product Type & Application
  5. 3.5 Global Dihydropyridine Vasodilators Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Dihydropyridine Vasodilators Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Dihydropyridine Vasodilators Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Dihydropyridine Vasodilators Tier 1, Tier 2, and Tier 3
4 Dihydropyridine Vasodilators Market by Type
  1. 4.1 Global Dihydropyridine Vasodilators Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Dihydropyridine Vasodilators Market Size by Type (2021-2032)
  3. 4.3 Global Dihydropyridine Vasodilators Market Size Share by Type (2021-2032)
5 Dihydropyridine Vasodilators Market by Application
  1. 5.1 Global Dihydropyridine Vasodilators Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Dihydropyridine Vasodilators Market Size by Application (2021-2032)
  3. 5.3 Global Dihydropyridine Vasodilators Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Teva Dihydropyridine Vasodilators Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Sine Pharma
  8. 6.2.1 Sine Pharma Company Information
  9. 6.2.2 Sine Pharma Business Overview
  10. 6.2.3 Sine Pharma Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Sine Pharma Dihydropyridine Vasodilators Product Portfolio
  12. 6.2.5 Sine Pharma Recent Developments
  13. 6.3 Shyndec Pharma
  14. 6.3.1 Shyndec Pharma Company Information
  15. 6.3.2 Shyndec Pharma Business Overview
  16. 6.3.3 Shyndec Pharma Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Shyndec Pharma Dihydropyridine Vasodilators Product Portfolio
  18. 6.3.5 Shyndec Pharma Recent Developments
  19. 6.4 Huanghai Pharma
  20. 6.4.1 Huanghai Pharma Company Information
  21. 6.4.2 Huanghai Pharma Business Overview
  22. 6.4.3 Huanghai Pharma Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Huanghai Pharma Dihydropyridine Vasodilators Product Portfolio
  24. 6.4.5 Huanghai Pharma Recent Developments
  25. 6.5 Novartis
  26. 6.5.1 Novartis Company Information
  27. 6.5.2 Novartis Business Overview
  28. 6.5.3 Novartis Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Novartis Dihydropyridine Vasodilators Product Portfolio
  30. 6.5.5 Novartis Recent Developments
  31. 6.6 Nanjing Easeheal Pharma
  32. 6.6.1 Nanjing Easeheal Pharma Company Information
  33. 6.6.2 Nanjing Easeheal Pharma Business Overview
  34. 6.6.3 Nanjing Easeheal Pharma Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Nanjing Easeheal Pharma Dihydropyridine Vasodilators Product Portfolio
  36. 6.6.5 Nanjing Easeheal Pharma Recent Developments
  37. 6.7 Lifeon Pharma
  38. 6.7.1 Lifeon Pharma Company Information
  39. 6.7.2 Lifeon Pharma Business Overview
  40. 6.7.3 Lifeon Pharma Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Lifeon Pharma Dihydropyridine Vasodilators Product Portfolio
  42. 6.7.5 Lifeon Pharma Recent Developments
  43. 6.8 Beijing Hongling Pharma
  44. 6.8.1 Beijing Hongling Pharma Company Information
  45. 6.8.2 Beijing Hongling Pharma Business Overview
  46. 6.8.3 Beijing Hongling Pharma Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Beijing Hongling Pharma Dihydropyridine Vasodilators Product Portfolio
  48. 6.8.5 Beijing Hongling Pharma Recent Developments
  49. 6.9 Bayer
  50. 6.9.1 Bayer Company Information
  51. 6.9.2 Bayer Business Overview
  52. 6.9.3 Bayer Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Bayer Dihydropyridine Vasodilators Product Portfolio
  54. 6.9.5 Bayer Recent Developments
  55. 6.10 AstraZeneca
  56. 6.10.1 AstraZeneca Company Information
  57. 6.10.2 AstraZeneca Business Overview
  58. 6.10.3 AstraZeneca Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 AstraZeneca Dihydropyridine Vasodilators Product Portfolio
  60. 6.10.5 AstraZeneca Recent Developments
  61. 6.11 Ingenus Pharmaceutical
  62. 6.11.1 Ingenus Pharmaceutical Company Information
  63. 6.11.2 Ingenus Pharmaceutical Business Overview
  64. 6.11.3 Ingenus Pharmaceutical Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Ingenus Pharmaceutical Dihydropyridine Vasodilators Product Portfolio
  66. 6.11.5 Ingenus Pharmaceutical Recent Developments
  67. 6.12 Hikma Pharmaceuticals
  68. 6.12.1 Hikma Pharmaceuticals Company Information
  69. 6.12.2 Hikma Pharmaceuticals Business Overview
  70. 6.12.3 Hikma Pharmaceuticals Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Hikma Pharmaceuticals Dihydropyridine Vasodilators Product Portfolio
  72. 6.12.5 Hikma Pharmaceuticals Recent Developments
  73. 6.13 Baxter International
  74. 6.13.1 Baxter International Company Information
  75. 6.13.2 Baxter International Business Overview
  76. 6.13.3 Baxter International Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Baxter International Dihydropyridine Vasodilators Product Portfolio
  78. 6.13.5 Baxter International Recent Developments
  79. 6.14 Astellas Pharma
  80. 6.14.1 Astellas Pharma Company Information
  81. 6.14.2 Astellas Pharma Business Overview
  82. 6.14.3 Astellas Pharma Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Astellas Pharma Dihydropyridine Vasodilators Product Portfolio
  84. 6.14.5 Astellas Pharma Recent Developments
  85. 6.15 Aguettant
  86. 6.15.1 Aguettant Company Information
  87. 6.15.2 Aguettant Business Overview
  88. 6.15.3 Aguettant Dihydropyridine Vasodilators Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Aguettant Dihydropyridine Vasodilators Product Portfolio
  90. 6.15.5 Aguettant Recent Developments
7 North America
  1. 7.1 North America Dihydropyridine Vasodilators Market Size (2021-2032)
  2. 7.2 North America Dihydropyridine Vasodilators Market Size by Type
  3. 7.2.1 North America Dihydropyridine Vasodilators Market Size by Type (2021-2026)
  4. 7.2.2 North America Dihydropyridine Vasodilators Market Size by Type (2027-2032)
  5. 7.2.3 North America Dihydropyridine Vasodilators Market Share by Type (2021-2032)
  6. 7.3 North America Dihydropyridine Vasodilators Market Size by Application
  7. 7.3.1 North America Dihydropyridine Vasodilators Market Size by Application (2021-2026)
  8. 7.3.2 North America Dihydropyridine Vasodilators Market Size by Application (2027-2032)
  9. 7.3.3 North America Dihydropyridine Vasodilators Market Share by Application (2021-2032)
  10. 7.4 North America Dihydropyridine Vasodilators Market Size by Country
  11. 7.4.1 North America Dihydropyridine Vasodilators Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Dihydropyridine Vasodilators Market Size by Country (2021-2026)
  13. 7.4.3 North America Dihydropyridine Vasodilators Market Size by Country (2027-2032)
  14. 7.4.4 North America Dihydropyridine Vasodilators Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Dihydropyridine Vasodilators Market Size (2021-2032)
  2. 8.2 Europe Dihydropyridine Vasodilators Market Size by Type
  3. 8.2.1 Europe Dihydropyridine Vasodilators Market Size by Type (2021-2026)
  4. 8.2.2 Europe Dihydropyridine Vasodilators Market Size by Type (2027-2032)
  5. 8.2.3 Europe Dihydropyridine Vasodilators Market Share by Type (2021-2032)
  6. 8.3 Europe Dihydropyridine Vasodilators Market Size by Application
  7. 8.3.1 Europe Dihydropyridine Vasodilators Market Size by Application (2021-2026)
  8. 8.3.2 Europe Dihydropyridine Vasodilators Market Size by Application (2027-2032)
  9. 8.3.3 Europe Dihydropyridine Vasodilators Market Share by Application (2021-2032)
  10. 8.4 Europe Dihydropyridine Vasodilators Market Size by Country
  11. 8.4.1 Europe Dihydropyridine Vasodilators Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Dihydropyridine Vasodilators Market Size by Country (2021-2026)
  13. 8.4.3 Europe Dihydropyridine Vasodilators Market Size by Country (2027-2032)
  14. 8.4.4 Europe Dihydropyridine Vasodilators Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Dihydropyridine Vasodilators Market Size (2021-2032)
  2. 9.2 China Dihydropyridine Vasodilators Market Size by Type
  3. 9.2.1 China Dihydropyridine Vasodilators Market Size by Type (2021-2026)
  4. 9.2.2 China Dihydropyridine Vasodilators Market Size by Type (2027-2032)
  5. 9.2.3 China Dihydropyridine Vasodilators Market Share by Type (2021-2032)
  6. 9.3 China Dihydropyridine Vasodilators Market Size by Application
  7. 9.3.1 China Dihydropyridine Vasodilators Market Size by Application (2021-2026)
  8. 9.3.2 China Dihydropyridine Vasodilators Market Size by Application (2027-2032)
  9. 9.3.3 China Dihydropyridine Vasodilators Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Dihydropyridine Vasodilators Market Size (2021-2032)
  2. 10.2 Asia Dihydropyridine Vasodilators Market Size by Type
  3. 10.2.1 Asia Dihydropyridine Vasodilators Market Size by Type (2021-2026)
  4. 10.2.2 Asia Dihydropyridine Vasodilators Market Size by Type (2027-2032)
  5. 10.2.3 Asia Dihydropyridine Vasodilators Market Share by Type (2021-2032)
  6. 10.3 Asia Dihydropyridine Vasodilators Market Size by Application
  7. 10.3.1 Asia Dihydropyridine Vasodilators Market Size by Application (2021-2026)
  8. 10.3.2 Asia Dihydropyridine Vasodilators Market Size by Application (2027-2032)
  9. 10.3.3 Asia Dihydropyridine Vasodilators Market Share by Application (2021-2032)
  10. 10.4 Asia Dihydropyridine Vasodilators Market Size by Country
  11. 10.4.1 Asia Dihydropyridine Vasodilators Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Dihydropyridine Vasodilators Market Size by Country (2021-2026)
  13. 10.4.3 Asia Dihydropyridine Vasodilators Market Size by Country (2027-2032)
  14. 10.4.4 Asia Dihydropyridine Vasodilators Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Dihydropyridine Vasodilators Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Dihydropyridine Vasodilators Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Dihydropyridine Vasodilators Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Dihydropyridine Vasodilators Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Dihydropyridine Vasodilators Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Dihydropyridine Vasodilators Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Dihydropyridine Vasodilators Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Dihydropyridine Vasodilators Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Dihydropyridine Vasodilators Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Dihydropyridine Vasodilators Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Dihydropyridine Vasodilators Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Dihydropyridine Vasodilators Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Dihydropyridine Vasodilators Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Dihydropyridine Vasodilators Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst